Correlation between longitudinal changes orexin levels and clinical characteristics in Parkinson’s disease.

The table shows the Spearman’s rank correlation coefficients for longitudinal changes in orexin levels and clinical characteristics. There were no significant correlations between longitudinal changes in orexin levels and clinical characteristics. 95%CI, 95% confidence interval; Δ-, increment of -; ESS, Epworth Sleepiness Scale; RBDQ, Rapid Eye Movement Sleep Behavior Disorder Questionnaire; HYscale, Hoehn and Yahr scale; MDS-UPDRS(I)—(IV), Movement Disorder Society—unified Parkinson’s Disease Rating Scale part 1 to 4; PDQ-39, Parkinson’s Disease Questionnaire; MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery; Olfactory, Olfactory identification score; SCOPA-AUT, Scales for Outcomes in Parkinson’s Disease-Autonomic; GDS-15, Geriatric Depression Scale; AS, Apathy Scale.
(XLSX)